Никонов Е.Л., Попова Е.Н. (ред.). Микробиота. М.: Медиа Сфера; 2019. 255 с. Режим доступа: https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/.https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/

Никонов Е.Л., Попова Е.Н. (ред.). Микробиота. М.: Медиа Сфера; 2019. 255 с. Режим доступа: https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/.https://endoexpert.ru/stati/monografiya_mikrobiota_pod_redaktsiey_e_l_nikonova_i_e_n_popovoy_2019/

Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.3..
DOI: 10.1371/journal.pbio.1002533.3

Tanaka M., Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66(4):515–522. doi: 10.1016/j.alit.2017.07.010..
DOI: 10.1016/j.alit.2017.07.010

Dunn A.B., Jordan S., Baker B.J., Carlson N.S. The Maternal Infant Microbiome: Considerations for Labor and Birth. MCN Am J Matern Child Nurs. 2017;42(6):318–325. doi: 10.1097/NMC.0000000000000373..
DOI: 10.1097/NMC.0000000000000373

Bäckhed F., Roswall J., Peng Y., Feng Q., Jia H., Kovatcheva-Datchary P. et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015;17(6):852. doi: 10.1016/j.chom.2015.04.004..
DOI: 10.1016/j.chom.2015.04.004

Matsuki T., Yahagi K., Mori H., Matsumoto H., Hara T., Tajima S. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun. 2016;7:11939. doi: 10.1038/ncomms11939..
DOI: 10.1038/ncomms11939

Nuriel-Ohayon M., Neuman H., Koren O. Microbial Changes during Pregnancy, Birth, and Infancy. Front Microbiol. 2016;7:1031. doi: 10.3389/fmicb.2016.01031..
DOI: 10.3389/fmicb.2016.01031

Gensollen T., Iyer S.S., Kasper D.L., Blumberg R.S. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–544. doi: 10.1126/science.aad9378..
DOI: 10.1126/science.aad9378

Thursby E., Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–1836. doi: 10.1042/BCJ20160510..
DOI: 10.1042/BCJ20160510

Adair K.L., Douglas A.E. Making a microbiome: the many determinants of host-associated microbial community composition. Curr Opin Microbiol. 2017;35:23–29. doi: 10.1016/j.mib.2016.11.002..
DOI: 10.1016/j.mib.2016.11.002

Hall A.B., Tolonen A.C., Xavier R.J. Human genetic variation and the gut microbiome in disease. Nat Rev Genet. 2017;18(11):690–699. doi: 10.1038/nrg.2017.63..
DOI: 10.1038/nrg.2017.63

Abdul-Aziz M.A., Cooper A., Weyrich L.S. Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies. Front Microbiol. 2016;7:1611. doi: 10.3389/fmicb.2016.01611..
DOI: 10.3389/fmicb.2016.01611

Harmsen H.J. M., de Goffau M.C. The Human Gut Microbiota. Adv Exp Med Biol. 2016;902:95–108. doi: 10.1007/978-3-319-31248-4_7..
DOI: 10.1007/978-3-319-31248-4_7

Jandhyala S.M., Talukdar R., Subramanyam C., Vuyyuru H., Sasikala M., Reddy D.N. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787–803. doi: 10.3748/wjg.v21.i29.8787..
DOI: 10.3748/wjg.v21.i29.8787

Lloyd-Price J., Abu-Ali G., Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. doi: 10.1186/s13073-016-0307-y..
DOI: 10.1186/s13073-016-0307-y

Shafquat A., Joice R., Simmons S.L., Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol. 2014;22(5):261–266. doi: 10.1016/j.tim.2014.01.011..
DOI: 10.1016/j.tim.2014.01.011

Nagai M., Obata Y., Takahashi D., Hase K. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis. Int Immunopharmacol. 2016;37:79–86. doi: 10.1016/j.intimp.2016.04.001..
DOI: 10.1016/j.intimp.2016.04.001

Flint H.J., Duncan S.H., Scott K.P., Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015;74(1):13–22. doi: 10.1017/S0029665114001463..
DOI: 10.1017/S0029665114001463

Meng X., Zhang G., Cao H., Yu D., Fang X., Vos W.M., Wu H. Gut dysbacteriosis and intestinal disease: mechanism and treatment. J Appl Microbiol. 2020;129(4):787–805. doi: 10.1111/jam.14661..
DOI: 10.1111/jam.14661

Gagliardi A., Totino V., Cacciotti F., Iebba V., Neroni B., Bonfiglio G. et al. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health. 2018;15(8):1679. doi: 10.3390/ijerph15081679..
DOI: 10.3390/ijerph15081679

Bäumler A.J., Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85–93. doi: 10.1038/nature18849..
DOI: 10.1038/nature18849

Amabebe E., Robert F.O., Agbalalah T., Orubu E.S. F. Microbial dysbiosisinduced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123(10):1127–1137. doi: 10.1017/S0007114520000380..
DOI: 10.1017/S0007114520000380

Kwak M.J., Kwon S.K., Yoon J.K., Song J.Y., Seo J.G., Chung M.J., Kim JF. Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function. Syst Appl Microbiol. 2016;39(7):429–439. doi: 10.1016/j.syapm.2016.07.004..
DOI: 10.1016/j.syapm.2016.07.004

Shang M., Sun J. Vitamin D/VDR, probiotics, and gastrointestinal diseases. Curr Med Chem. 2017;24(9):876–887. doi: 10.2174/0929867323666161202150008..
DOI: 10.2174/0929867323666161202150008

Yamamoto E.A., Jørgensen T.N. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol. 2020;10:3141. doi: 10.3389/fimmu.2019.03141..
DOI: 10.3389/fimmu.2019.03141

Celiberto L.S., Bedani R., Rossi E.A., Cavallini D.C. U. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr. 2017;57(9):1759–1768. doi: 10.1080/10408398.2014.941457..
DOI: 10.1080/10408398.2014.941457

Tidjani Alou M., Lagier J.-C., Raoult D. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Hum Microbiome J. 2016;1:3–11. doi: 10.1016/j.humic.2016.09.001..
DOI: 10.1016/j.humic.2016.09.001

Magruder M., Sholi A.N., Gong C., Zhang L., Edusei E., Huang J. et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. doi: 10.1038/s41467-019-13467-w..
DOI: 10.1038/s41467-019-13467-w

Forbes J.D., Van Domselaar G., Bernstein C.N. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol. 2016;7:1081. doi: 10.3389/fmicb.2016.01081..
DOI: 10.3389/fmicb.2016.01081

Simpson H.L., Campbell B.J. Review article: dietary fibre – microbiota interactions. Aliment Pharmacol Ther. 2015;42(2):158–179. doi: 10.1111/apt.13248..
DOI: 10.1111/apt.13248

Filippis F.D., Pellegrini N., Vannini L., Jeffery I.B., Storia A.L., Laghi L. et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65(11):1812–1821. doi: 10.1136/gutjnl-2015-309957..
DOI: 10.1136/gutjnl-2015-309957

Sakkas H., Bozidis P., Touzios C., Kolios D., Athanasiou G., Athanasopoulou E. et al. Nutritional Status and the Influence of the Vegan Diet on the Gut Microbiota and Human Health. Medicina (Kaunas). 2020;56(2):88. doi: 10.3390/medicina56020088..
DOI: 10.3390/medicina56020088

David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi: 10.1038/nature12820..
DOI: 10.1038/nature12820

Murphy E.A., Velazquez K.T., Herbert K.M. Influence of High-Fat-Diet on Gut Microbiota: A Driving Force for Chronic Disease Risk. Curr Opin Clin Nutr Metab Care. 2015;18(5):515–520. doi: 10.1097/MCO.0000000000000209..
DOI: 10.1097/MCO.0000000000000209

Smith-Brown P., Morrison M., Krause L., Davies P.S. W. Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Sci Rep. 2016;6:32385. doi: 10.1038/srep32385..
DOI: 10.1038/srep32385

Arrieta M.-C., Stiemsma L.T., Dimitriu P.A., Thorson L., Russell S., YuristDoutsch S. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152. doi: 10.1126/scitranslmed.aab2271..
DOI: 10.1126/scitranslmed.aab2271

Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi: 10.1038/nrgastro.2014.66..
DOI: 10.1038/nrgastro.2014.66

Sebastián Domingo J.J. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol. 2017;40(6):417–429. doi: 10.1016/j.gastrohep.2016.12.003..
DOI: 10.1016/j.gastrohep.2016.12.003

Daliri E., Lee B.H. New perspectives on probiotics in health and disease. Food Sci Hum Wellness. 2015;4(2):56–65. doi: 10.1016/j.fshw.2015.06.002..
DOI: 10.1016/j.fshw.2015.06.002

Guarner F., Sanders M.E., Eliakim R., Fedorak R., Gangl A., Garisch J. et al. Probiotics and prebiotics. World Gastroenterology Organisation. 2017. Available at: https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english

Guarner F., Sanders M.E., Eliakim R., Fedorak R., Gangl A., Garisch J. et al. Probiotics and prebiotics. World Gastroenterology Organisation. 2017. Available at: https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.https://www.worldgastroenterology.org/guidelines/globalguidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english

Ouwehand A.C., Forssten S., Hibberd A.A., Lyra A., Stahl B. Probiotic approach to prevent antibiotic resistance. Ann Med. 2016;48(4):246–255. doi: 10.3109/07853890.2016.1161232..
DOI: 10.3109/07853890.2016.1161232

Korpela K., Salonen A., Virta L.J., Kumpu M., Kekkonen R.A., de Vos W.M. Lactobacillus rhamnosus GG Intake Modifies Preschool Children’s Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. PLoS One. 2016;11(4):e0154012. doi: 10.1371/journal.pone.0154012..
DOI: 10.1371/journal.pone.0154012

Ivashkin V.T., Mayev I.V., Abdulganieva D.I., Alekseenko S.A., Ivashkina N.Yu., Korochanskaya N.V. et al. Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults. Rossiyskiy zhurnal gastroehnterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(2):76–89. (In Russ.) doi: 10.22416/1382-4376-2020-30-2-76-89..
DOI: 10.22416/1382-4376-2020-30-2-76-89

Yoo J.Y., Kim S.S. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients. 2016;8(3):173. doi: 10.3390/nu8030173..
DOI: 10.3390/nu8030173

Sun J., Buys N. Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Ann Med. 2015;47(6):430–440. doi: 10.3109/07853890.20 15.1071872..
DOI: 10.3109/07853890.20 15.1071872

Kim C.J., Walmsley S.L., Raboud J.M., Kovacs C., Coburn B., Rousseau R. et al. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. HIV Clin Trials. 2016;17(4):147–157. doi: 10.1080/15284336.2016.1184827..
DOI: 10.1080/15284336.2016.1184827

Cani P.D., Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol. 2015;32:21–27. doi: 10.1016/j.copbio.2014.10.006..
DOI: 10.1016/j.copbio.2014.10.006

Patel R., DuPont H.L. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(2 Suppl.):108–121. doi: 10.1093/cid/civ177..
DOI: 10.1093/cid/civ177

Martín R., Miquel S., Benevides L., Bridonneau C., Robert V., Hudault S. et al. Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic. Front Microbiol. 2017;8:1226. doi: 10.3389/fmicb.2017.01226..
DOI: 10.3389/fmicb.2017.01226

Cani P.D., Everard A. Akkermansia muciniphila: a novel target controlling obesity, type 2 diabetes and inflammation? Med Sci (Paris). 2014;30(2):125–127. (In French) doi: 10.1051/medsci/20143002003..
DOI: 10.1051/medsci/20143002003

Schneeberger M., Everard A., Gómez-Valadés A.G., Matamoros S., Ramírez S., Delzenne N.M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. doi: 10.1038/srep16643..
DOI: 10.1038/srep16643

Miller L.E., Ouwehand A.C., Ibarra A. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Ann Gastroenterol. 2017;30(6):629–639. doi: 10.20524/aog.2017.0192..
DOI: 10.20524/aog.2017.0192

Asha M.Z., Khalil S.F. H. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome. Sultan Qaboos Univ Med J. 2020;20(1):e13–24. doi: 10.18295/squmj.2020.20.01.003..
DOI: 10.18295/squmj.2020.20.01.003

Derwa Y., Gracie D.J., Hamlin P.J., Ford A.C. Systematic review with metaanalysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(4):389–400. doi: 10.1111/apt.14203..
DOI: 10.1111/apt.14203

Ganji‐Arjenaki M., Rafieian‐Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233(3):2091–2103. doi: 10.1002/jcp.25911..
DOI: 10.1002/jcp.25911

Oka A., Sartor R.B. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Dig Dis Sci. 2020;65(3):757–788. doi: 10.1007/s10620-020-06090-z..
DOI: 10.1007/s10620-020-06090-z

Luthold R.V., Fernandes G.R., Franco-de-Moraes A.C., Folchetti L.G. D., Ferreira S.R. G. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76–86. doi: 10.1016/j.metabol.2017.01.007..
DOI: 10.1016/j.metabol.2017.01.007

Yacoub R., Kaji D., Patel S.N., Simoes P.K., Busayavalasa D., Nadkarni G.N. et al. Association between probiotic and yogurt consumption and kidney disease: insights from NHANES. Nutr J. 2016;15:10. doi: 10.1186/s12937-016-0127-3..
DOI: 10.1186/s12937-016-0127-3

Firouzi S., Haghighatdoost F. The effects of prebiotic, probiotic, and synbiotic supplementation on blood parameters of renal function: A systematic review and meta-analysis of clinical trials. Nutrition. 2018;51–52:104–113. doi: 10.1016/j.nut.2018.01.007..
DOI: 10.1016/j.nut.2018.01.007

Hadi A., Mohammadi H., Miraghajani M., Ghaedi E. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Crit Rev Food Sci Nutr. 2019;59(15):2494–2505. doi: 10.1080/10408398.2018.1458021..
DOI: 10.1080/10408398.2018.1458021

Kristensen N.B., Bryrup T., Allin K.H., Nielsen T., Hansen T.H., Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8(1):52. doi: 10.1186/s13073-016-0300-5..
DOI: 10.1186/s13073-016-0300-5

Satokari R. Modulation of Gut Microbiota for Health by Current and NextGeneration Probiotics. Nutrients. 2019;11(8):1921. doi: 10.3390/nu11081921..
DOI: 10.3390/nu11081921

Sanders M.E. Probiotics and microbiota composition. BMC Med. 2016;14(1):82. doi: 10.1186/s12916-016-0629-z..
DOI: 10.1186/s12916-016-0629-z

Falony G., Joossens M., Vieira-Silva S., Wang J., Darzi Y., Faust K. et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560–564. doi: 10.1126/science.aad3503..
DOI: 10.1126/science.aad3503

Mullish B.H., Quraishi M.N., Segal J.P., McCune V. L., Baxter M., Marsden G.L. et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67(11):1920–1941. doi: 10.1136/gutjnl-2018-316818..
DOI: 10.1136/gutjnl-2018-316818

Saha S., Mara K., Pardi D.S., Khanna S. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 2021;(April 08). (In press) doi: 10.1053/j.gastro.2021.01.010..
DOI: 10.1053/j.gastro.2021.01.010

Grehan M.J., Borody T.J., Leis S.M., Campbell J., Mitchell H., Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010;44(8):551–561. doi: 10.1097/MCG.0b013e3181e5d06b..
DOI: 10.1097/MCG.0b013e3181e5d06b

Blanchaert C., Strubbe B., Peeters H. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol Belg. 2019;82(4):519–528. Available at: https://pubmed.ncbi.nlm.nih.gov/31950808/.https://pubmed.ncbi.nlm.nih.gov/31950808/

Blanchaert C., Strubbe B., Peeters H. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol Belg. 2019;82(4):519–528. Available at: https://pubmed.ncbi.nlm.nih.gov/31950808/.https://pubmed.ncbi.nlm.nih.gov/31950808/

Sokol H., Landman C., Seksik P., Berard L., Montil M., Nion-Larmurier I. et al. Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study. Microbiome. 2020;8(1):12. doi: 10.1186/s40168-020-0792-5..
DOI: 10.1186/s40168-020-0792-5

Caldeira L.F., Borba H.H., Tonin F.S., Wiens A., Fernandez-Llimos F., Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One. 2020;15(19):e0238910. doi: 10.1371/journal.pone.0238910..
DOI: 10.1371/journal.pone.0238910

El-Salhy M., Mazzawi T. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2018;12(5):439–445. doi: 10.1080/17474124.2018.1447380..
DOI: 10.1080/17474124.2018.1447380

Xu D., Chen V.L., Steiner C.A., Berinstein J.A., Eswaran S., Waljee A.K. et al. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019;114(7):1043–1050. doi: 10.14309/ajg.0000000000000198..
DOI: 10.14309/ajg.0000000000000198

Ianiro G., Eusebi L.H., Black C.J., Gasbarrini A., Cammarota G., Ford A.C. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(3):240–248. doi: 10.1111/apt.15330..
DOI: 10.1111/apt.15330

Myneedu K., Deoker A., Schmulson M.J., Bashashati M. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis. United European Gastroenterol J. 2019;7(8):1033–1041. doi: 10.1177/2050640619866990..
DOI: 10.1177/2050640619866990

Kao D., Roach B., Park H., Hotte N., Madsen K., Bain V., Tandon P. Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology. 2016;63(1):339–340. doi: 10.1002/hep.28121..
DOI: 10.1002/hep.28121

Bajaj J.S., Kassam Z., Fagan A., Gavis E.A., Liu E., Cox I.J. et al. Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial. Hepatology. 2017;66(6):1727–1738. doi: 10.1002/hep.29306..
DOI: 10.1002/hep.29306

Bajaj J.S., Salzman N.H., Acharya C., Sterling R.K., White M.B., Gavis E.A. et al. Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. Hepatology. 2019;70(5):1690–1703. doi: 10.1002/hep.30690..
DOI: 10.1002/hep.30690

Vemuri R., Shankar E.M., Chieppa M., Eri R., Kavanagh K. Beyond Just Bacteria: Functional Biomes in the Gut Ecosystem Including Virome, Mycobiome, Archaeome and Helminths. Microorganisms. 2020;8(4):483. doi: 10.3390/microorganisms8040483..
DOI: 10.3390/microorganisms8040483

DeFilipp Z., Bloom P.P., Soto M.T., Mansour M.K., Sater M.R. A., Huntley M. H et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019;381(21):2043–2050. doi: 10.1056/NEJMoa1910437..
DOI: 10.1056/NEJMoa1910437

Cammarota G., Ianiro G., Tilg H., Rajilić-Stojanović M., Kump P., Satokari R. et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569–580. doi: 10.1136/gutjnl-2016–313017..
DOI: 10.1136/gutjnl-2016–313017